Original research contributions are for manuscripts that encompass the broad range of innovative and impactful clinical and basic research in the field of cerebrovascular disorders. These manuscripts should present comprehensive research with a robust methodology and results sections. The maximum length for original manuscripts is 5,500 words. Please note the publication fees in the Costs to Authors section. The total number of figures and/or tables is limited to 6. Each figure may contain up to 4 panels (i.e., parts A to D) and must conform to the requirements for figures described in that section of the instructions to authors.
Brief reports are for manuscripts with less complete data sets than would be appropriate for original contributions that present novel and impactful clinical and basic research of a more preliminary nature. Maximum length is 2,000 words, including up to 15 references. The total number of figures and/or tables is limited to 3.
Progress or Topical Reviews
This category presents a review of advances related to important research and clinical topics relevant to some aspect of cerebrovascular disease. They will generally be invited by the editors but unsolicited reviews will also be accepted for editorial review. Invited reviews will also undergo peer review but except in rare circumstances will not be subject to rapid triage and early rejection. Manuscripts should not exceed 5,500 words with 6 figures/tables. Please do NOT include an abstract in review papers. An introduction or background section will suffice.
Comments and Opinions
In this category, authors summarize the present state of knowledge in some aspect of cerebrovascular disease without the objectivity required in a Progress Review. Maximum length is 5,500 words with a total of 6 figures/tables. Please do NOT include an abstract in review papers. An introduction or background section will suffice.
These articles may summarize an event or a topic of interest to the readers of Stroke. Authors must query the editors before writing Special Reports to determine possible interest in such articles. Maximum length is 5,500 words with a total of 6 tables/figures.
Illustrative Teaching Cases (Online-Only Publication)
This series is directed primarily at residents and fellows. An actual case is presented, discussed, and the teaching points are noted. Each article presents bulleted Take Home Points. The purpose of this series is not to focus on esoteric or unusual cases, but rather to review and stress points that trainees are likely to encounter during their training and beyond. The focus should not be related to a technical advance or how to do a procedure. The focus of each case will be varied. In some cases, the key feature will be a review of neuroanatomy. Another may review types of testing for a specific condition or review the differential diagnosis for a particular symptom. The articles are short and easy to read and should be a quick way to review clinical “pearls” in cerebrovascular disease. You may wish to read several of our published Teaching Cases for a better understanding of the series.
Maximum length for this article is 2,000 words. The word limit includes title page, main body of text, bulleted take home points, acknowledgments, sources of funding, disclosures, references, figure legends, and tables. There may be no more than 3 combined figures or tables. The manuscript does not have an abstract, and contains as few references as possible and no more than 10 references total.
InterSECT: International Stroke Early Career and Training
The mission of the section is to publish articles of interest to stroke specialists early in their careers. The target audience is neurologists, neurosurgeons, radiologists, emergency medicine physicians, and those from other specialties who plan to make stroke the focus of their professional careers. Because those physicians interested in stroke include clinicians and scientists, the articles in InterSECT will also range widely in their focus and perspective. Articles will include topics related to building a practice in clinical care and to developing an academic career.
We look to the community of Vascular Neurology fellows to help identify topics and authors for articles. Members of the stroke community who have ideas for an article, or who would like to propose writing for the section, are invited to contact Grant Davis at firstname.lastname@example.org. Articles published in InterSECT will be ≤2000 words in length and are allowed 10 references and 1 table or figure.
Letters to the Editor (Online-Only Publication)
Updated Jan 12, 2018: This forum expresses views about articles published in Stroke or presents ideas or findings of scientific interest that do not constitute original research. Letters must reference a Stroke article published in print within the past 4 weeks. Letters are limited to Original Articles, Brief Reports, Comments and Opinions, and Topical Reviews. The Editor encourages letter authors to pose a question to which the article authors may respond. The maximum length is 750 words including no more than 5 references and 3 authors. Tables, figures, and data supplements are prohibited. Please use the journal formatting for titles of Letters to the Editor. Example: Letter by Author et al. Regarding Article, “Article Title.” Letters may be shortened or edited by the Editorial Office. The editor invites responses to letters as appropriate. Response Letter titles use this format: Response by Author et al. to Letter Regarding Article, ”Article Title.”
Letters to the Editor on AHA/ASA Scientific Statements and Guidelines will be reviewed by the journal. The Editor may accept or decline the Letter. In either case, the journal will forward the Letter to the AHA/ASA. If the Letter to the Editor is accepted for publication in Stroke, the journal may also publish a Response (if any) from the AHA/ASA. The AHA/ASA may post the Letter and Response (if any) on its Correspondence page. Because Letters sent to the AHA/ASA are brought to the attention of the Writing Committee chair/co-chairs the AHA/ASA Manuscript Oversight Committee, please be patient in awaiting a final reply.
Clinical and Research Innovations. Discontinued.
Case Reports. Discontined. We do not publish case reports in any format.
Instructions for Authors Menu
|General Preparation Instructions||Revised Manuscripts|
|Research Guidelines||Costs to Authors|
|How to Submit a Manuscript||Journal Policies|
|Tips for Submission||Submit Your Manuscript Now|